Saxenda and Wegovy are authorised for weight management and Mounjaro is authorised for both diabetes and weight management
Key Takeaways IGF-1 LR3 must be reconstituted with bacteriostatic water (0.9% benzyl alcohol) using slow-wall injection technique at 1mL per 2030 seconds to prevent protein denaturation from mechanical shear stress
Retatrutide targets three distinct receptor pathways (GLP-1, GIP, and glucagon) to suppress appetite, enhance fat metabolism, and promote significant weight loss averaging 24% over 48 weeks
Orforglipron is a new oral small molecule GLP-1R agonist administered once daily
Certain patterns may increase the likelihood of weight regain: returning to previous eating habits low physical activity levels inconsistent routines high stress levels restrictive dieting approaches lack of long-term planning Identifying potential challenges early can help individuals maintain progress
Leukocyte adhesion molecules As vital constituents of the immune system, ECs act as conduits for migrating immune cells
